NEW YORK (360Dx) – Roche announced late Friday that it has received US Food and Drug Administration clearance for its Elecsys Anti-Müllerian hormone (AMH) assay.

According to the company, the assay is the first approved fully automated AMH test available in the US. Roche said that the assay was approved via the FDA's de novo classification option.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.